BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31611329)

  • 1. Use of High-Cost Cancer Treatments in Academic and Nonacademic Practice.
    Mitchell AP; Kinlaw AC; Peacock-Hinton S; Dusetzina SB; Sanoff HK; Lund JL
    Oncologist; 2020 Jan; 25(1):46-54. PubMed ID: 31611329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commercial Versus Medicaid Insurance and Use of High-Priced Anticancer Treatments.
    Mitchell AP; Kinlaw AC; Peacock-Hinton S; Dusetzina SB; Winn AN; Sanoff HK; Lund JL
    Oncologist; 2024 Jun; 29(6):527-533. PubMed ID: 38484395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What factors influence minority use of National Cancer Institute-designated cancer centers?
    Huang LC; Ma Y; Ngo JV; Rhoads KF
    Cancer; 2014 Feb; 120(3):399-407. PubMed ID: 24452674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of National Cancer Institute-designated cancer center status: observed variation in surgical care depends on the level of evidence.
    In H; Neville BA; Lipsitz SR; Corso KA; Weeks JC; Greenberg CC
    Ann Surg; 2012 May; 255(5):890-5. PubMed ID: 22504278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute-designated cancer centers in California.
    Ho G; Wun T; Muffly L; Li Q; Brunson A; Rosenberg AS; Jonas BA; Keegan THM
    Cancer; 2018 May; 124(9):1938-1945. PubMed ID: 29451695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of care setting in the delivery of high-value colon cancer care.
    Veenstra CM; Epstein AJ; Liao K; Morris AM; Pollack CE; Armstrong KA
    Cancer; 2014 Oct; 120(20):3237-44. PubMed ID: 24954628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Payment methods for healthcare providers working in outpatient healthcare settings.
    Jia L; Meng Q; Scott A; Yuan B; Zhang L
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011865. PubMed ID: 33469932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancer.
    Griffiths RI; Barron RL; Gleeson ML; Danese MD; O'Hagan A; Chia VM; Legg JC; Lyman GH
    Pharmacoeconomics; 2012 Feb; 30(2):103-18. PubMed ID: 21967155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining Value for Pancreatic Surgery in Early-Stage Pancreatic Cancer.
    Bateni SB; Gingrich AA; Hoch JS; Canter RJ; Bold RJ
    JAMA Surg; 2019 Oct; 154(10):e193019. PubMed ID: 31433465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in patients, surgical complexity, and outcomes after cancer surgery at National Cancer Institute-designated cancer centers compared to other hospitals.
    Merkow RP; Bentrem DJ; Chung JW; Paruch JL; Ko CY; Bilimoria KY
    Med Care; 2013 Jul; 51(7):606-13. PubMed ID: 23604012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Cancer Care Expenditures and Utilization for Surgery by Hospital Type Among Patients With Private Insurance.
    Takvorian SU; Yasaitis L; Liu M; Lee DJ; Werner RM; Bekelman JE
    JAMA Netw Open; 2021 Aug; 4(8):e2119764. PubMed ID: 34342648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice-Level Variation in Molecular Testing and Use of Targeted Therapy for Patients With Non-Small Cell Lung Cancer and Colorectal Cancer.
    Roberts TJ; Kehl KL; Brooks GA; Sholl L; Wright AA; Landrum MB; Keating NL
    JAMA Netw Open; 2023 Apr; 6(4):e2310809. PubMed ID: 37115543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Payer-Negotiated Price Variation and Relationship to Surgical Outcomes for the Most Common Cancers at NCI-Designated Cancer Centers.
    Sankaran R; O'Connor J; Nuliyalu U; Diaz A; Nathan H
    Ann Surg Oncol; 2024 Jul; 31(7):4339-4348. PubMed ID: 38506934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Maxillofacial Prosthetics for the Surgically Treated Patient at National Cancer Institute-Designated Comprehensive Cancer Centers.
    Rosen EB; Palin CL; Huryn JM; Wong RJ
    Laryngoscope; 2019 Feb; 129(2):409-414. PubMed ID: 30247745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.